KCT0001508
Completed
未知
The effect ot topical recombinant human epidermal growth factor and moisturizers which contain skin identical lipids on xerosis: a randomized, double blinded controlled clinical trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the skin and subcutaneous tissue
- Sponsor
- Samsung Medical Center
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.All patients were between the ages of 20 and 70 (male or female)
- •2\.All patients had a diagnosis of xerosis as defined by the xerosis severity scale (XSS) presented by Rogers et al and scores of at least 3 on both shins.
- •3\.All of the included patients signed written informed consent for their participation.
Exclusion Criteria
- •Patients were excluded if there was known or suspected sensitivity to test ingredients, current history of any dermatologic diseases requiring treatment (such as psoriasis, atopic dermatitis and eczema), a condition that could interfere with the study’s conduct, use of oral/topical corticosteroids or immunosuppressants, or light therapy within 4 weeks prior to the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
To compare the clinical outcome of topical recombinant human epidermal growth factor and conventional saline dressing in management of diabetic foot ulcers - a randomised controlled trialCTRI/2024/06/068922Aarupadai veedu medical College and hospital
Not yet recruiting
Phase 3
Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressingCTRI/2024/05/067239Dr A Sneha Daffodil
Recruiting
Phase 3
The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scarmild to moderate rolling and shallow boxcar acne scarsTCTR20201201003none20
Completed
Not Applicable
Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trialStriae albastriae alba,recombinant-human epidermal growth factor,fractional carbon dioxide laserTCTR20180610001Thammasat University24
Not yet recruiting
Phase 4
Healing of mouth soft tissues using topically applied gel.CTRI/2023/01/049177OFFICE OF DGDS